Please assess the completion status of the following clinical trial:

Trial Title: Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* healthy adults who meet AABB (formerly known as the American Association of Blood Banks) criteria for whole blood donation~* females incapable of becoming pregnant~* males agreeing to use contraception during trial~Exclusion Criteria:~* pregnancy or nursing~* abnormal medical history (bleeding disorders, anemia, myocardial ischemia, uncontrolled hypertension, heart disease, epilepsy)~* major surgery~* use of drugs affecting coagulation or RBC function~* recent participation in other trials which may confound results

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mirasol Illumination Dose #1 (Type: EXPERIMENTAL): Whole blood units treated with Mirasol at Illumination dose #1 (A1) of 22 Joules per milliliter of red blood cells (J/mL RBCs)
- Mirasol Illumination Dose #2 (Type: EXPERIMENTAL): Whole Blood units treated with Mirasol at Illumination dose #2 (A2) of 33 J/mL RBCs
- Mirasol Illumination Dose #3 (Type: EXPERIMENTAL): Whole Blood units treated with Mirasol at Illumination dose #3 (A3) of 44 J/mL RBCs

Based on this trial design, predict the completion outcome and termination type (if applicable).